PET Evaluation of Response After 1 Course of Chemotherapy as Predictor of Treatment Outcome.
Evaluation of Prognostic and Predictive Value of PETSCAn in ColoRectal Cancer (CRC)
Sponsor: Jules Bordet Institute
A observational or N/A phase clinical study on Colorectal Cancer Metastatic and Early Response Evaluation, this trial is completed. The trial is conducted by Jules Bordet Institute and has accumulated 6 data snapshots since 2006. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Jun 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Jules Bordet Institute
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Brussels, Belgium